T cell response to new melanoma antigen linked to relapse-free survival
Monday, October 20, 2008 - 10:35
in Health & Medicine
Melanoma patients infused with a special type of tumor-fighting T cell are more likely to survive without relapse, suggests a new study by researchers in France. Their report will be published online on October 20 in the Journal of Experimental Medicine.